Instructions for CME/NCPD: Complete the pre-test, listen to the
audio and view the slides, complete the post test, complete the
evaluation form and hit submit. You will be asked to enter your name
and email address on the pre-test, evaluation and post-test. If you
close your internet browser without completing the post test, you
will have ONE more opportunity to complete. A score of 70% must be
achieved on the post test to receive continuing education credits.
If you do not pass the post test after two attempts, you will not be
eligible to try again. Once you complete the evaluation form and
score 70% or higher on your post test, you will automatically be
given your certificate.
To print or save your certificate, you will need to click on the
“download” button and either print or save.
This activity is intended for healthcare professionals practicing in
managed care environments.
This activity is supported by
an educational grant from
Alzheimer’s disease is the most common form of dementia, affecting
an estimated 5 million people in the United States. It is a
cognitive disorder that includes behavioral impairment that
interferes with social and occupational functioning. Over time the
disease destroys large areas of the brain, resulting in cellular
loss and dysfunction, a gradual loss of memory, problems with
reasoning or judgment, disorientation, difficulty in learning, loss
of language skills, and decline in the ability to perform routine
tasks. Although not all memory loss indicates Alzheimer’s disease,
one in ten people over 65 years of age, and over half of those over
85 have Alzheimer’s disease. By the year 2050, over 15 million
Americans may be affected with the disease. Alzheimer’s disease care
costs $172 billion annually in the United States alone. However,
advances in the science underlying Alzheimer’s are emerging at a
rapid rate with a large number of potential agents undergoing
Currently, an autopsy or brain biopsy is the only way to make a
definitive diagnosis of Alzheimer’s disease. Diagnosing Alzheimer's
requires careful medical evaluation, including medical history,
mental status testing, physical and neurological exam, blood tests
and brain imaging. PCPs are increasingly called on to provide care
for cognitively impaired individuals, playing critical roles in
detecting early symptoms of dementia, communicating with patients
and caregivers about the disease, coordinating with specialists on
multimodal therapeutic plans, and following up to tailor treatment,
minimize complications, and head off medical crises. The importance
of early diagnosis cannot be understated. As the use of biomarkers
continues to grow, the potential for catching Alzheimer’s disease
even earlier is crucial to improving outcomes. While there is no
cure for Alzheimer’s disease or a way to stop or slow its
progression, there are pharmacologic and non-pharmacologic options
that may help treat symptoms.
Upon completion of this
activity, participants will be able to:
Assess recent advances in clinical
data and guidelines for diagnosis and treatment of dementia
Discuss optimal diagnostic testing
strategies for early detection and evaluation of Alzheimer's
disease and related dementias
Evaluate the safety and efficacy
data of new and emerging treatment therapies, including a close
look at disease modifying therapies
Analyze investigational treatment
strategies and neurodegenerative alterations in patients with
Examine the multidisciplinary roles
in managing dementia and the interventions for supporting
||Marc Agronin, MD
Senior Vice President for Behavioral Health
Miami Jewish Health
serves as a consultant for Biogen, Lilly and Otsuka. He
has served on the speaker's bureau for Allergan. His
presentation has been peer reviewed for any bias.
MD has no financial relationships with ineligible
companies to disclose.
Jeremy Williams has no financial relationships with
ineligible companies to disclose.
Jacqueline Cole, RN, MS, CMCN has no financial
relationships with ineligible companies to disclose.
NAMCP and/or the presenter
has copyright or has received permissions for use of
materials provided in this activity.
Accreditation & Designation
This activity has been planned and implemented in accordance with
the accreditation requirements and policies of the Accreditation
Council for Continuing Medical Education (ACCME) through the joint
providership of the National Association of Managed Care Physicians
(NAMCP) and American Association of Managed Care Nurses (AAMCN). The
National Association of Managed Care Physicians is accredited by the
ACCME to provide continuing medical education for physicians.
NAMCP designates this enduring material for a maximum of 1 AMA
PRA Category 1 credit(s)TM. Each
physician should claim credit commensurate with the extent of their
participation in the activity.
The American Association of Managed Care Nurses is accredited as a
provider of nursing continuing professional development by the
American Nurses Credentialing Center's Commission on Accreditation.
Nurses who complete this activity and achieve a passing score will
receive 1 hour in nursing continuing professional development.
This activity has been approved by the American Board of Managed
Care Nursing for 1.0 contact hours toward CMCN recertification
This activity is supported by an educational grant from
NAMCP and/or this website does not
provide medical advice, diagnosis or treatment. NAMCP does not
endorse or imply endorsement of the content on any linked website.
This website is to be used as an informational resource. With any
health related concern, consult with your physician or healthcare
Click Here To Continue